Latest Articles

Professor Dame Ijeoma Uchegbu discusses the nanoparticle delivery system behind the non-addictive pain medication Envelta and how this treatment could help overcome issues surrounding efficacy and off-target effects.

The HUMANOID Center at UC San Diego is pioneering organoid research aimed at improving the reliability and reproducibility of these models, ultimately increasing drug testing accuracy and revolutionizing biomedical science.

Discover the science of rheology—exploring how materials flow and deform, essential for industries like food, polymers and pharmaceuticals, and gain key insights into viscosity, elasticity and practical testing techniques.

Allyship in STEMM requires active listening, unlearning biases and advocating for equity. This article explores how inclusion drives innovation and how small actions can create meaningful change in building a more diverse, inclusive community.

The innovation, he says, could transform the way scientists measure and address genomic breaks in gene-editing systems.

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But reports of unpleasant side effects have prompted further studies. This article explores the latest research on these drugs.

C-Path, a nonprofit organization created to improve drug development, has been working to facilitate the adoption of MPS as drug development tools in regulatory science. In this interview, we learn how.

This article explores methods to enhance efficiency in the drug discovery and development pipeline, focusing on optimizing processes and exploring innovations that could streamline the path from research to approval.

Associate Professor Qing Zhong shared insights on AI breakthroughs in proteomics and multiomics, challenges in data sharing and his vision for a high-resolution lens on biology that could redefine science and healthcare.

This article explores how multi-agent generative AI frameworks are revolutionizing drug development.